Dentsply Sirona Inc
XRAY: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| kF | LOCK|@p | LOCK|rKryV$N |
Dentsply Sirona Earnings: Weak Recovery Momentum Unchanged as Soft Volume Weighs on Results
Dentsply Sirona delivered revenue and adjusted EPS declines of 4% and 1%, respectively, during the second quarter. Both figures came ahead of FactSet consensus. Full-year guidance for revenue ($3.5-3.6 billion) and EPS ($1.40-1.50) is unchanged. Shares are down 3% after hours.
